Given the strong association of CYB561D2 with survival of patients and the important roles of CYB561D2 in the homeostasis of oxidation–reduction reaction, we hypothesize that CYB561D2 is potentially involved in the pathogenesis of gliomas. Here, CYB561D2 is linked to central nervous system cancer.